David W. Cescon

Princess Margaret Cancer Centre ORCID: 0000-0002-1080-0998

1

h-index

1

Publications

1,658

Citations

Publications

1 shown

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

Javier Cortés , David W. Cescon , Hope S. Rugo +97 more

2020 The Lancet 1658 citations

Frequent Co-Authors

Javier Cortés

Vall d'Hebron Institute of Oncology

Hope S. Rugo

University of California, San Francisco

Zbigniew Nowecki

The Maria Sklodowska-Curie National Research Institute of Oncology

Seock‐Ah Im

Seoul National University Hospital

Mastura Md Yusof

Hospital Kuala Lumpur

Carlos Gallardo

Fundación Arturo López Pérez

Researcher Info

h-index: 1
Publications: 1
Citations: 1,658
Institution: Princess Margaret Cancer Centre

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-1080-0998

Impact Metrics

h-index 1

h-index: Number of publications with at least h citations each.